Radiocurability is associated with interstitial fluid pressure in human tumor xenografts.

Interstitial fluid pressure (IFP) has been shown to be an independent prognostic parameter for disease-free survival in cervical carcinoma patients treated with radiation therapy. However, the underlying mechanisms are not fully understood. The main aims of this study were to investigate whether tumor radiocurability may be associated with IFP and, if so, to identify possible mechanisms. Human melanoma xenografts transplanted intradermally or in window chamber preparations in BALB/c nu/nu mice were used as preclinical tumor models. Radiation dose resulting in 50% local tumor control was higher by a factor of 1.19 +/- 0.06 in tumors with IFP > or = 9 mm Hg than in tumors with IFP < or = 7 mm Hg. Tumor IFP was positively correlated to vessel segment length and vessel tortuosity and was inversely correlated to vessel density. Compared with tumors with low IFP, tumors with high IFP showed high resistance to blood flow, high frequency of Po(2) fluctuations, and high fractions of acutely hypoxic cells, whereas the fraction of radiobiologically hypoxic cells and the fraction of chronically hypoxic cells did not differ between tumors with high and tumors with low IFP. IFP showed a significant correlation to the fraction of acutely hypoxic cells, probably because both parameters were determined primarily by the microvascular resistance to blood flow. Therefore, the observed association between tumor radiocurability and IFP was most likely an indirect consequence of a strong relationship between IFP and the fraction of acutely hypoxic cells.

[1]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .

[2]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[3]  W A Brock,et al.  Predictive Assays of Tumor Radiocurability , 1988, American journal of clinical oncology.

[4]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[5]  E. Rofstad.  Influence of cellular radiation sensitivity on local tumor control of human melanoma xenografts given fractionated radiation treatment. , 1991, Cancer research.

[6]  R K Jain,et al.  Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. , 1992, Cancer research.

[7]  E. Rofstad,et al.  Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. , 1994, British Journal of Cancer.

[8]  R. Jain,et al.  Lack of general correlation between interstitial fluid pressure and oxygen partial pressure in solid tumors. , 1995, Microvascular research.

[9]  Raleigh,et al.  Measuring Tumor Hypoxia. , 1996, Seminars in radiation oncology.

[10]  R K Jain,et al.  Delivery of Molecular Medicine to Solid Tumors , 1996, Science.

[11]  H. Lyng,et al.  Interstitial fluid pressure, perfusion rate and oxygen tension in human melanoma xenografts. , 1996, The British journal of cancer. Supplement.

[12]  E. Rofstad,et al.  Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points. , 1998, British Journal of Cancer.

[13]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[14]  A. Fyles,et al.  The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. , 1999, International journal of radiation oncology, biology, physics.

[15]  E. Rofstad,et al.  Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. , 1999, International journal of radiation biology.

[16]  E. Rofstad.  Microenvironment-induced cancer metastasis , 2000, International journal of radiation biology.

[17]  D. Hedley,et al.  Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. , 2001, Cancer research.

[18]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[19]  E. Rofstad,et al.  Microvascular permeability to macromolecules in human melanoma xenografts assessed by contrast-enhanced MRI--intertumor and intratumor heterogeneity. , 2001, Magnetic resonance imaging.

[20]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[21]  E. Rofstad,et al.  Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. , 2002, Cancer research.

[22]  E. Rofstad,et al.  Temporal heterogeneity in oxygen tension in human melanoma xenografts , 2003, British Journal of Cancer.

[23]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[24]  Peter Vaupel,et al.  Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.

[25]  Anthony Fyles,et al.  The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure. , 2004, Seminars in radiation oncology.

[26]  E. Rofstad,et al.  Tumor-line specific pO(2) fluctuations in human melanoma xenografts. , 2004, International journal of radiation oncology, biology, physics.

[27]  E. Rofstad,et al.  Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[28]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[29]  A. Fyles,et al.  Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Nicholas Denko,et al.  Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment , 2006, Molecular Cancer Research.

[31]  V. Yang,et al.  Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours , 2008, BMC Cancer.

[32]  Dai Fukumura,et al.  Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize , 2007, Journal of cellular biochemistry.

[33]  E. Rofstad,et al.  Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis , 2007, Clinical Cancer Research.

[34]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[35]  E. Rofstad,et al.  Temporal heterogeneity in blood supply in human tumor xenografts. , 2008, Neoplasia.

[36]  Anthony Fyles,et al.  Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. , 2008, Future oncology.

[37]  E. Rofstad,et al.  Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging. , 2008, Neoplasia.

[38]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[39]  E. Rofstad,et al.  Detection of Different Hypoxic Cell Subpopulations in Human Melanoma Xenografts by Pimonidazole Immunohistochemistry , 2008, Radiation research.

[40]  Kristine Gulliksrud,et al.  Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  E. Rofstad,et al.  Blood supply in melanoma xenografts is governed by the morphology of the supplying arteries. , 2009, Neoplasia.

[42]  R. Bicknell,et al.  Anticancer strategies involving the vasculature , 2009, Nature Reviews Clinical Oncology.